Adam Lacy-Hulbert
December 6, 2024

Benaroya Research Institute’s Dr. Adam Lacy-Hulbert Receives Puget Sound Business Journal Researcher of the Year Award

Exceptional immunological research recognized for efforts to prevent disease

The Puget Sound Business Journal (PSBJ) is honoring Adam Lacy-Hulbert, PhD, for its 2024 Researcher of the Year Award, recognizing his work to better understand how immune system diseases begin and how to prevent them. Dr. Lacy-Hulbert’s team uses molecular and cell biology approaches to uncover how innate immune system cells and processes promote health.

As a fundamental immunologist, Dr. Lacy-Hulbert focuses on cells, molecules and other finite details in the immune system. However, Dr. Lacy-Hulbert also has a unique ability to zoom out, understand the big picture, and find ways to turn lab discoveries into life-changing care. In leading Benaroya Research Institute’s (BRI’s) Center for Systems Immunology, Dr. Lacy-Hulbert is bringing new, leading-edge technologies and more to BRI. This includes implementing data visualization tools to allow for easier identification of patterns and building creative teams that include experts from many fields — from bioinformatics to virtual reality — to fuel answers to pressing questions and new discoveries.

“It’s an honor to have PSBJ recognize the work we do here at BRI to predict, prevent, and cure autoimmune diseases,” says Dr. Lacy-Hulbert. “Research is a team effort, and our work would not be possible without many different people and organizations funding and supporting our mission.”

Recipients of PSBJ’s sixth annual Health Care Leadership Awards were recognized at an awards luncheon on Thursday, December 5, at Benaroya Hall in downtown Seattle.

Featured BRI Building Exterior 2024

About Benaroya Research Institute

Benaroya Research Institute (BRI) is a world leader in human immune system research. BRI works to advance the science that will predict, prevent, reverse and cure immune system diseases like allergies, asthma, cancer and autoimmune diseases. BRI accelerates discovery through laboratory breakthroughs in immunology that are then translated to clinical therapies. We believe that a breakthrough in one immune system disease can lead to progress against them all, and work tirelessly toward our vision of a healthy immune system for everyone. BRI is a world-renowned independent nonprofit research institute affiliated with Virginia Mason Franciscan Health and based in Seattle.

To learn more, visit benaroyaresearch.org and connect with us on Facebook, Instagram, Threads, LinkedIn, X and YouTube.